1434133-34-2Relevant academic research and scientific papers
Design, synthesis, and evaluation of NDGA analogues as potential anti-ischemic stroke agents
Huang, Lili,Wang, Jiabing,Chen, Liping,Zhu, Min,Wu, Shoubiao,Chu, Shenghui,Zheng, Yuantie,Fan, Ziliang,Zhang, Jiafeng,Li, Wulan,Chen, Dahui,Yang, Xiufei,Wang, Sicen,Qiu, Peihong,Wu, Jianzhang
, p. 1165 - 1173 (2018)
Exogenous supplementation of antioxidants with ROS scavenging activity would be a potential therapy to cerebral ischemia-reperfusion injury in stroke. In the present study, a series of NDGA analogues with attenuation oxidative stress by directly scavenging ROS and indirectly through keap1/Nrf2/ARE pathway activation were designed and synthesized. All analogues were found to effectively remove ROS directly by DPPH radical scavenging assay, and compound 3a conferred potent protection from the oxidative injury in PC12 cells via promoting Nrf2 to translocate into nucleus and increasing expression of heme oxygenase-1(HO-1), where strongly reduced intracellular ROS level indirectly. More importantly, 3a significantly reduced brain infarction after cerebral ischemia-reperfusion injury in rats subjected to transient middle cerebral artery occlusion (MCAO). Overall, our findings shown compound 3a could serve as a promising compound for the treatment of stroke.
Design, synthesis, and antihypertensive activity of curcumin-inspired compounds via ACE inhibition and vasodilation, along with a bioavailability study for possible benefit in cardiovascular diseases
Zhuang, Xiao-Dong,Liao, Li-Zhen,Dong, Xiao-Bian,Hu, Xun,Guo, Yue,Du, Zhi-Min,Liao, Xin-Xue,Wang, Li-Chun
, p. 129 - 139 (2016/01/15)
This study describes the synthesis of a novel series of curcumin-inspired compounds via a facile synthetic route. The structures of these derivatives were ascertained using various spectroscopic and analytic techniques. The pharmacological effects of the target analogs were assessed by assaying their inhibition of angiotensin-converting enzyme (ACE). All of the synthesized derivatives exhibited considerable inhibition of ACE, with half-maximal inhibitory concentrations ranging from 1.23 to 120.32 μM. In a docking analysis with testicular ACE (tACE), the most promising inhibitor (4j) was efficiently accommodated in the deep cleft of the protein cavity, making close interatomic contacts with Glu162, His353, and Ala356, comparable with lisinopril. Compounds 4i, 4j, 4k, and 4l were further selected for determination of their vasodilator activity (cardiac output and stroke volume) on isolated rat hearts using the Langendorff technique. The bioavailability of compound 4j was determined in experimental mice.
Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents
Wu, Jianzhang,Zhang, Yali,Cai, Yuepiao,Wang, Jian,Weng, Bixia,Tang, Qinqin,Chen, Xiangjian,Pan, Zheer,Liang, Guang,Yang, Shulin
, p. 3058 - 3065 (2013/07/25)
We previously reported the design and discovery of three series of 5-carbon linker-containing mono-carbonyl analogs of curcumin (MCACs) as excellent anti-inflammatory agents. In continuation of our ongoing research, we designed and synthesized the fourth
